We read with great interest the article by Fööldi et al. about the effect of obesity on COVID‐19. The authors evaluated the risk of different levels of obesity on COVID‐19 and found obesity was a significant risk factor for invasive mechanical ventilation (IMV) and intensive care unit (ICU) admission for patients with COVID‐19. This is a timely and exhaustive study. However, we have several concerns. First, by combing limited studies (N = 6 for IMV and N = 5 for ICU) in the forest plot, the results were not stable in the sensitive analysis by omitting one study each time. Moreover, some studies had greater than a 40%‐70% weighting for the primary outcomes, which suggested a large selection of studies. For example, in the results of ICU admission, the weight of Lighter et al. 1 was 74%, and the results were not significant (OR: 1.07, 95% confidence interval (CI): 0.74–1.56) when the Lighter et al. 1 was excluded. Also, the phenomenon was observed in the results of IMV when Simonnet et al. 2 was excluded in the sensitively analysis. The above mentioned reduced the robustness of present results. Second, an association was observed with obesity when body mass index (BMI) was considered as a categorical variable. However, whether there is an exposure–effect association between BMI and COVID‐19 was not clear. Based on available data presented in Földi's meta‐analysis, we further systematically searched the databases (Pubmed, medRxiv, Embase) and added nine studies 3 , 4 , 5 , 6 , 7 , 8 , 9 , 10 and have evaluated pooled exposure–effect odd ratios (ORs) for the impact of increasing BMI on COVID‐19. Exposure–effect risk was calculated by the robust error meta‐regression method. 11 As shown in Figure 1, BMI was associated with IMV, severe COVID‐19, and hospitalized death in a non‐linear manner (P nonlinearity = .018 for IMV, P nonlinearity = .031 for severe COVID‐19, P nonlinearity = .0067 for hospitalized death). The summary ORs for a 5‐unit increment in BMI was 1.43 (95% CI: 1.17–1.76) for IMV, 1.22 (95% CI: 1.13–1.31) for severe COVID‐19, and 1.06 (95% CI: 1.03–1.09) for hospitalized death.
FIGURE 1.

Exposure–effect impact of body mass index (BMI) on invasive mechanical ventilation (IMV), severity, and hospitalized death in patients with COVID‐19. Solid line in red represents fitted linear trend and corresponding upper/lower 95% confidence interval (CI); lines with long dashes in black represent fitted non‐linear trend and corresponding upper/lower 95% CI. (A) Exposure–effect association between BMI and IMV. P nonlinearity = .018, OR = 1.43 (95% CI: 1.17–1.76) per 5 kg/m2 of BMI increment; (B) exposure–effect association between BMI and severe COVID‐19. P nonlinearity = 0.031, OR = 1.22 (95% CI: 1.13–1.31) per 5 kg/m2 of BMI increment; (C) exposure–effect association between BMI and hospitalized death. P nonlinearity = 0.0067, OR = 1.06 (95% CI: 1.03–1.09) per 5 kg/m2 of BMI increment
Third, the authors used funnel plots for detecting potential publication bias and found possibility of publication bias. However, funnel plots are under powered when only few studies (N < 10) were included in the meta‐analysis according to the guidelines. 12 , 13 Therefore, it could be more appropriate to mention the known limitations of these methods because of inadequate numbers of included trials to properly assess a funnel plot, rather than claiming use of any test and further possibility of publication bias.
FUNDING INFORMATION
This work was supported in part by the National Natural Science Foundation of China (No. 81760050, 81760048) and the Jiangxi Provincial Natural Science Foundation for Youth Scientific Research (No. 20192ACBL21037).
CONFLICT OF INTEREST
No conflict of interest was declared.
Menglu Liu and Chao Deng contributed equally.
Contributor Information
Yujie Zhao, Email: 184231892@qq.com.
Xiao Liu, Email: kellyclarkwei@vip.qq.com.
REFERENCES
- 1. Lighter J, Phillips M, Hochman S, et al. Obesity in patients younger than 60 years is a risk factor for COVID‐19 hospital admission. Clin Infect Dis. 2020;71(15):896‐897. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Simonnet A, Chetboun M, Poissy J, et al. High prevalence of obesity in severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) requiring invasive mechanical ventilation. Obesity (Silver Spring). 2020;28(7):1195‐1199. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Al‐Sabah SK, Al‐Haddad M, Al Youha S, Jamal MH, AlMazeedi S. COVID‐19: impact of obesity and diabetes in disease severity. medRxiv. 2020. 10.1101/2020.05.24.20111724 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Cai Q, Huang D, Ou P, et al. COVID‐19 in a designated infectious diseases hospital outside Hubei Province, China. Allergy. 2020;75(7):1742‐1752. [DOI] [PubMed] [Google Scholar]
- 5. Suleyman G, Fadel RA, Malette KM, et al. Clinical characteristics and morbidity associated with coronavirus disease 2019 in a series of patients in metropolitan Detroit. JAMA Network Open. 2020;3(6):e2012270 10.1001/jamanetworkopen.2020.12270 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Dreher M, Kersten A, Bickenbach J, et al. The characteristics of 50 hospitalized COVID‐19 patients with and without ARDS. Dtsch Arztebl Int. 2020;117(16):271‐278. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Petrilli CM, Jones SA, Yang J, et al. Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ. 2020:m1966 10.1136/bmj.m1966 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8. Murillo‐Zamora E, Hernandez‐Suarez CM. Survival in adult inpatients with COVID‐19. medRxiv. 2020. 10.1101/2020.05.25.20110684 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Audit ICN and Centre R. ICNARC report on COVID‐19 in critical care: 24 April 2020. 2020.
- 10. Yates T, Razieh C, Zaccardi F, Seidu S, Davies MJ, Khunti K. Obesity, walking pace and risk of severe COVID‐19: Analysis of UK Biobank. medRxiv. 2020. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Xu C, Sar D. The robust error meta‐regression method for dose‐response meta‐analysis. Int J Evid Based Healthc. 2018;16(3):138–144. [DOI] [PubMed] [Google Scholar]
- 12. Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta‐analyses of randomised controlled trials. BMJ. 2011;343:d4002. [DOI] [PubMed] [Google Scholar]
- 13. Higgins JP and Green S. Cochrane handbook for systematic reviews of interventions version 5.2.0 [updated March 2017]The Cochrane Collaboration, 2017. Available from http://handbook.cochrane.org.chanpter: 10.4.3.1 Recommendations on testing for funnel plot asymmetry. 2011.
